Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 217

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Accuracy of β -D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis

Open access
Karageorgopoulos, D.E., Qu, J.-M., Korbila, I.P., Zhu, Y.-G., Vasileiou, V.A., Falagas, M.E.·2013·Clinical Microbiology and Infection
DOI 10.1111/j.1469-0691.2011.03760.x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1469-0691.2011.03760.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 45

  1. Kaplan, 2000, Epidemiology of human immunodeficiency virus-associated opportunistic infections in the united states in the era of highly active antiretroviral therapy, Clin Infect Dis, 30, S5, 10.1086/313843 · DOI · Paper page
  2. Castro, 1992, 1993 revised classification system for hiv infection and expanded surveillance case definition for aids among adolescents and adults, MMWR Recomm Rep, 41, 1
  3. Huang, 1995, Suspected pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful?, Am J Respir Crit Care Med, 151, 1866, 10.1164/ajrccm.151.6.7767533 · DOI
  4. Russian, 1995, Pneumocystis carinii in africa: An emerging pathogen?, Lancet, 346, 1242, 10.1016/S0140-6736(95)91854-X · doi:10.1016/s0140-6736(95)91854-x
  5. Thomas, 2004, Pneumocystis pneumonia, N Engl J Med, 350, 2487, 10.1056/NEJMra032588 · DOI · Paper page
  6. Torres, 2006, Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of pneumocystis jiroveci pneumonia in cancer patients, Eur J Clin Microbiol Infect Dis, 25, 382, 10.1007/s10096-006-0149-4 · DOI
  7. Jules-Elysee, 1990, Aerosolized pentamidine: effect on diagnosis and presentation of pneumocystis carinii pneumonia, Ann Intern Med, 112, 750, 10.7326/0003-4819-112-10-750 · DOI · Paper page
  8. Fischl, 1988, Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for pneumocystis carinii pneumonia in aids, JAMA, 259, 1185, 10.1001/jama.259.8.1185 · doi:10.1001/jama.259.8.1185 · Paper page
  9. Skelly, 2003, S-adenosylmethionine concentrations in diagnosis of pneumocystis carinii pneumonia, Lancet, 361, 1267, 10.1016/S0140-6736(03)12984-4 · DOI
  10. Vassallo, 2000, Isolated pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses, J Immunol, 164, 3755, 10.4049/jimmunol.164.7.3755 · DOI
  11. Arends, 2008, Bivariate random effects meta-analysis of roc curves, Med Decis Making, 28, 621, 10.1177/0272989X08319957 · DOI · Paper page
  12. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  13. Macaskill, 2010, Chapter 10: analysing and presenting results
  14. Acosta, 2011, Clin Microbiol Infect, 17, 1053, 10.1111/j.1469-0691.2010.03357.x · DOI
  15. Damiani, 2011, Serum (1–>3)-beta-d-glucan levels in primary infection and pulmonary colonization with pneumocystis jirovecii., J Clin Microbiol, 49, 2000, 10.1128/JCM.00249-11 · DOI
  16. de Boer, 2010, Beta-d-glucan and s-adenosylmethionine serum levels for the diagnosis of pneumocystis pneumonia in hiv-negative patients: a prospective study, J Infect, 62, 93, 10.1016/j.jinf.2010.10.007 · DOI
  17. Held, 2010, Serum (1–>3)-beta-d-glucan measurement as early indicator for pneumocystis jirovecii pneumonia and evaluation of its prognostic value, Clin Microbiol Infect, 17, 595, 10.1111/j.1469-0691.2010.03318.x · DOI
  18. Desmet, 2009, Serum (1-3)-beta-d-glucan as a tool for diagnosis of pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy, J Clin Microbiol, 47, 3871, 10.1128/JCM.01756-09 · DOI
  19. Koo, 2009, Diagnostic performance of the (1–>3)-beta-d-glucan assay for invasive fungal disease, Clin Infect Dis, 49, 1650, 10.1086/647942 · DOI · Paper page
  20. Nakamura, 2009, Clinical utility of serum beta-d-glucan and kl-6 levels in pneumocystis jirovecii pneumonia, Intern Med, 48, 195, 10.2169/internalmedicine.48.1680 · DOI
  21. Watanabe, 2009, Serum (1–>3) beta-d-glucan as a noninvasive adjunct marker for the diagnosis of pneumocystis pneumonia in patients with aids, Clin Infect Dis, 49, 1128, 10.1086/605579 · DOI
  22. Obayashi, 2008, Reappraisal of the serum (1–>3)-beta-d-glucan assay for the diagnosis of invasive fungal infections–a study based on autopsy cases from 6 years, Clin Infect Dis, 46, 1864, 10.1086/588295 · DOI · Paper page
  23. Persat, 2008, Contribution of the (1–>3)-beta-d-glucan assay for diagnosis of invasive fungal infections, J Clin Microbiol, 46, 1009, 10.1128/JCM.02091-07 · DOI · Paper page
  24. Tasaka, 2007, Serum indicators for the diagnosis of pneumocystis pneumonia, Chest, 131, 1173, 10.1378/chest.06-1467 · DOI · Paper page
  25. Iikuni, 2006, Evaluation of pneumocystis pneumonia infection risk factors in patients with connective tissue disease, Mod Rheumatol, 16, 282, 10.3109/s10165-006-0502-6 · doi:10.3109/s10165-006-0502-6
  26. Mori, 1999, Clinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: aspergillosis, candidosis, and pneumocystosis, Nippon Ishinkin Gakkai Zasshi, 40, 223, 10.3314/jjmm.40.223 · DOI
  27. Yasuoka, 1996, (1–>3) beta-d-glucan as a quantitative serological marker for pneumocystis carinii pneumonia, Clin Diagn Lab Immunol, 3, 197, 10.1128/CDLI.3.2.197-199.1996 · DOI
  28. Karageorgopoulos, 2011, B-d-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis, Clin Infect Dis, 52, 750, 10.1093/cid/ciq206 · DOI · Paper page
  29. Fujii, 2007, Pneumocystis pneumonia in patients with hiv infection: clinical manifestations, laboratory findings, and radiological features, J Infect Chemother, 13, 1, 10.1007/s10156-006-0484-5 · DOI
  30. Marty, 2007, (1–>3)beta-d-glucan assay positivity in patients with pneumocystis (carinii) jiroveci pneumonia, Ann Intern Med, 147, 70, 10.7326/0003-4819-147-1-200707030-00018 · DOI
  31. Shimizu, 2005, (1–>3)-beta-d glucan is a diagnostic and negative prognostic marker for pneumocystis carinii pneumonia in patients with connective tissue disease, Clin Exp Rheumatol, 23, 678
  32. Sax, 2011, Blood (1–>3)-beta-d-glucan as a diagnostic test for hiv-related pneumocystis jirovecii pneumonia, Clin Infect Dis, 53, 197, 10.1093/cid/cir335 · DOI
  33. Digby, 2003, Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients, Clin Diagn Lab Immunol, 10, 882, 10.1128/CDLI.10.5.882-885.2003 · DOI
  34. Ellis, 2008, Assessment of the clinical utility of serial beta-d-glucan concentrations in patients with persistent neutropenic fever, J Med Microbiol, 57, 287, 10.1099/jmm.0.47479-0 · DOI
  35. Marty, 2009, Role of (1–>3)-beta-d-glucan in the diagnosis of invasive aspergillosis, Med Mycol, 47, S233, 10.1080/13693780802308454 · DOI
  36. Acosta, 2011, Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-beta-d-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease, Eur J Clin Microbiol Infect Dis
  37. Racil, 2010, Difficulties in using 1,3-{beta}-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies–high frequency of false-positive results and their analysis, J Med Microbiol, 59, 1016, 10.1099/jmm.0.019299-0 · DOI
  38. Cuenca-Estrella, 2011, Detection and investigation of invasive mould disease, J Antimicrob Chemother, 66, i15, 10.1093/jac/dkq438 · DOI
  39. Finkelman, 2010, pneumocystis jirovecii infection: cell wall (1 → 3)-β-d-glucan biology and diagnostic utility, Crit Rev Microbiol, 36, 271, 10.3109/1040841X.2010.484001 · DOI
  40. Calderon, 2010, Pneumocystis infection in humans: diagnosis and treatment, Expert Rev Anti Infect Ther, 8, 683, 10.1586/eri.10.42 · DOI
  41. Pisculli, 2008, Use of a serum beta-glucan assay for diagnosis of hiv-related pneumocystis jiroveci pneumonia in patients with negative microscopic examination results, Clin Infect Dis, 46, 1928, 10.1086/588564 · DOI
  42. Leigh, 1993, DNA amplification by the polymerase chain reaction to detect sub-clinical pneumocystis carinii colonization in hiv-positive and hiv-negative male homosexuals with and without respiratory symptoms, Respir Med, 87, 525, 10.1016/0954-6111(93)90008-N · doi:10.1016/0954-6111(93)90008-n
  43. Shimizu, 2009, Serum markers in interstitial pneumonia with and without pneumocystis jirovecii colonization: a prospective study, BMC Infect Dis, 9, 47, 10.1186/1471-2334-9-47 · DOI
  44. Odabasi, 2004, Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome, Clin Infect Dis, 39, 199, 10.1086/421944 · DOI · Paper page
  45. Leeflang, 2008, Systematic reviews of diagnostic test accuracy, Ann Intern Med, 149, 889, 10.7326/0003-4819-149-12-200812160-00008 · DOI · Paper page

Cited by

See all 217

Metadata

Authors
Karageorgopoulos, D. E., Qu, J.-M., Korbila, I. P., Zhu, Y.-G., Vasileiou, V. A., & Falagas, M. E.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2013-01
Volume
19
Issue
1
Pages
39-49
ISSN
1198-743X (ISSN-L)
DOI
10.1111/j.1469-0691.2011.03760.x
OpenAlex
W1550793468
Cited by
217
References
2
FWCI
0.85
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accuracy of β -D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. https://app.cochat.ai/papers/10.1111/j.1469-0691.2011.03760.x
The paper
Karageorgopoulos, D. E., Qu, J.-M., Korbila, I. P., Zhu, Y.-G., Vasileiou, V. A., & Falagas, M. E. (2013). Accuracy of β -D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clinical Microbiology and Infection. https://doi.org/10.1111/j.1469-0691.2011.03760.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.